Amicus Therapeutics
Price & Volume
Stats
See moreOpen | $6.64 |
Previous Close | $6.70 |
Day Range | $6.64-$6.87 |
52W Range | $6.20-$12.65 |
Market Cap | $2B |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $528.2M |
Revenue Growth (YoY) | 30.1% |
Gross Profit (12 Mos) | $475.3M |
Diluted EPS | -$0.18 |
News
See moreYahoo Finance • 9 days ago
Is Amicus Therapeutics, Inc. (FOLD) the Best Low Cost Stock to Buy According to Billionaires?
Yahoo Finance • 11 days ago
AMICUS STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term Investors to Contact the Firm
Yahoo Finance • 2 months ago
Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
Yahoo Finance • 2 months ago
Kuehn Law Encourages Investors of Amicus Therapeutics, Inc. to Contact Law Firm
About
CEO | Mr. Bradley L. Campbell M.B.A. |
Address | 47 Hulfish Street, Princeton, NJ, United States, 08542 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 499 |
